Adding Ociperlimab to Tislelizumab Fails to Improve Advanced Esophageal Cancer Survival
In the randomized phase II AdvanTIG-203 trial, adding the anti-TIGIT antibody ociperlimab to tislelizumab did not significantly improve response rates ...
In the randomized phase II AdvanTIG-203 trial, adding the anti-TIGIT antibody ociperlimab to tislelizumab did not significantly improve response rates ...
A prospective study demonstrates that longitudinal increases in circulating Granzyme B and activated cytotoxic lymphocytes track therapeutic response and survival ...
Researchers at Mount Sinai received NIH funding to test whether advanced MRI scans of brain stiffness and blood flow can ...
A systematic literature review reveals that escalated doses of EGFR tyrosine kinase inhibitors may improve clinical outcomes for selected non-small ...
A retrospective multicenter study found that baseline CT-defined sarcopenia is independently associated with significantly shorter progression-free survival in patients with ...
Researchers evaluate how surgical de-escalation, regional chemotherapy, and emerging molecular biomarkers are refining individualized management strategies for advanced epithelial ovarian ...
A retrospective study of 176 advanced hepatocellular carcinoma patients demonstrated that combining transcatheter arterial chemoembolization with systemic therapy significantly prolonged ...
A narrative review evaluates trial evidence indicating that KELIM chemosensitivity scores, rather than BRCA or homologous recombination deficiency status, predict ...
A comprehensive review in Discover Plants examines how advanced CRISPR platforms, including base and prime editing, enable precise, double-strand-break-free genomic ...
A population-based study of Hong Kong adults links ultrasound-measured liver steatosis and stiffness to significantly higher odds of advanced cardiovascular-kidney-metabolic ...
A systematic review of 81 studies indicates that advanced cell therapies and biomaterial scaffolds promote intervertebral disc regeneration in experimental ...
Targeted therapies inhibiting the PI3K, AKT, and mTOR signaling axis demonstrate significant progression-free survival benefits for patients with endocrine-resistant, hormone ...
A meta-analysis of 13 randomized trials found that adding immune checkpoint inhibitors does not significantly improve survival outcomes in unselected ...
A retrospective cohort study found that local tumor response following hypofractionated radiotherapy combined with systemic therapy was independently associated with ...
A comprehensive pharmacological review details how engineered nanocarriers, responsive hydrogels, and minimally invasive devices overcome multi-compartment ear barriers to improve ...
A first-in-human trial of actinium-225-PSMA-CY313 demonstrated manageable salivary toxicity alongside preliminary biochemical and radiographic responses in heavily pretreated metastatic castration-resistant ...
A narrative review establishes a common framework for selecting advanced oxidation, adsorption, and membrane separation processes to treat refractory organic ...
A study in JNCCN found that broad-based genomic sequencing before treatment was associated with longer survival in patients with advanced ...
A synthetic microcapsule phantom mimicking both intra- and extracellular water compartments successfully validates time-dependent diffusion magnetic resonance imaging and biophysical ...
Single-cell transcriptomic profiling of lung adenocarcinoma tissues reveals how undifferentiated cancer stem cell subpopulations expand in late-stage tumors and harbor ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.